Participants were treated in a Florida health network between 2014 and 2024.Glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases appetite and slows digestion of food.All of the patients had been diagnosed with an autoimmune disease and obesity, and researchers analyzed more than 10 years of their health data.Results showed that those taking a GLP-1 drug had a:17% lower risk of blood clots forming in a vein31% lower risk of a blood clot causing a pulmonary embolism in a lung13% lower risk of stroke21% lower odds of ER visits44% reduced risk of death"The 44% reduction in all-cause mortality observed among patients with obesity and co-occurring autoimmune disease is a striking finding that demands our attention, said Dr
But for general weight management and metabolic health, these plant-based additions can be helpful
The new obesity drug coverage will be enabled through a pilot program designed to cover a majority of beneficiaries under Medicare Part D, which are the program's prescription drug plans
There are seven approved GLP-1 drugs in the U.S
Material and methods of research: Studies conducted on laboratory animals, rats, males and females
Use sterile water only for single-dose reconstitution where the entire vial is used immediately